We Welcome Mr. Moin ur Rehman as the Company’s new CEO effective from 28th February 2024

Re-opening of Line-II production after successful installation of machinery w.e.f. July 10, 2023

Nutraceutical Plant - Inauguration 15, March 2023

Mrs Navin Salim Merchant, Independent Director of the company has successfully completed her SECP approved Director Training Program from December 10th to 13th 2019

Otsuka launches new molecule in Gastroenterology segment for Gastritis and Gastric Ulcers

OPL Launched Mucosta (Rebamipide) 100mg tablets - anti-gastritis and anti-gastric ulcer agent in Pakistan

ACCA Approved Employer Certificate 2018 received by the CEO of OPL, Mr. Hanif Sattar on behalf of the Company.

Notices to Shareholders

By striving to think differently, by challenging established ways of thinking, and by exploring paths of discovery that nobody else has thought of, Otsuka will continue to push the

The medical devices unit took yet another initiative by entering into “Orthopedic Implants market” through the launch of Microport Orthopedic Knee Implants.

ACCA Approved Employer 2017 –Trainee Development, Gold for Otsuka Pakistan Limited

The shareholders’ factory visit had been performed successfully on Tuesday, January 23, 2018